JPRN-UMIN000007666已完成未知
Early therapy with lyposomal amphotericin B (L-AMB) for chronic pulmonary aspergillosis - Lyposomal amphotericin B for chronic pulmonary aspergillosis
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable(—)
- 性别
- All
入选标准
- 未提供
排除标准
- •1.Patients who received L-AMB within one month before the time of enrollment 2.Patients who newly started antifungal agents within three month before the time of enrollment 3.Patients with simple aspergilloma, invasive pulmonary aspergillosis, or allergic bronchopulmonary aspergollosis 4.Pregnant patients
研究者
相似试验
已完成
2 期
Phase II study of liposomal amphotericin B for febrile neutropenia.(C-SHOT1001)Hematological malignanciesJPRN-UMIN000003185Center for Supporting Hematology-Oncology Trials80
进行中(未招募)
2 期
iposomal amphotericin B for the treatment of Bangladeshi patients with visceral leishmaniasis.ACTRN12609001029280The United Nations Children's Fund (UNICEF)/ The United Nations Development Programme (UNDP) /World Bank /World Health Organization (WHO) Special Programme for Research and Training in Tropical Diseases (TDR)35
进行中(未招募)
不适用
ebulized liposomial Amphotericin B as rescue treatment of pulmonary and or sinusal invasive fungal infection - NDInvasive fungal infection of the respiratory tractMedDRA version: 6.1Level: HLTClassification code 10017537EUCTR2006-005031-21-ITISTITUTO GIANNINA GASLINI
已完成
2 期
iposomal amphotericin B for the treatment of Nepalese patients with visceral leishmaniasis.Visceral LeishmaniasisInfection - Other infectious diseasesACTRN12610000130066The United Nations Children's Fund (UNICEF)/ The United Nations Development Programme (UNDP) /World Bank /World Health Organization (WHO) Special Programme for Research and Training in Tropical Diseases (TDR)35
招募中
不适用
Empirical treatment of liposomal amphotericin B for febrile neutropenia. that persists despite broad-spectrum antibacterial therapyfebrile neutropeniaJPRN-UMIN000005163The first department of internal medicine, University of Fukui50
